FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006048863> ?p ?o ?g. }

• W2006048863 endingPage "316" @default.
• W2006048863 startingPage "308" @default.
• W2006048863 abstract "Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle in which a life-threatening, hypermetabolic syndrome is induced by exposure of susceptible patients to halogenated general anaesthetics and/or succinylcholine. Dantrolene sodium, the only drug effective for treatment of malignant hyperthermia, has low water solubility that makes its clinical use difficult. The aim of this study was to investigate the potency of azumolene, a 30-fold more water-soluble analogue, in comparison to the prototype dantrolene sodium, on mammalian and human skeletal muscles. The twitches of extensor digitorum longus and soleus muscles from mice were inhibited by azumolene with IC(50) of 2.8 +/- 0.8 and 2.4 +/- 0.6 microM, respectively. The IC(50) of dantrolene sodium in these muscles was 1.6 +/- 0.4 and 3.5 +/- 1.2 microM, respectively, with no difference in comparison to azumolene. Previous in vitro exposure of mouse soleus muscle to azumolene and dantrolene sodium (10 microM) significantly inhibited 8 mM caffeine-induced contractures. Azumolene was just effective as dantrolene sodium in relaxing caffeine-induced contractures of mouse soleus muscle. Intravenous injection caused dose-dependent decreases in twitches of guinea pig gastrocnemius muscle with IC(50) of 1.2 +/- 0.1 and 1.5 +/- 0.2 mg/kg for azumolene and dantrolene sodium, respectively. Azumolene, 10 microM, was effective in blocking and reversing caffeine-induced contracture of human malignant hyperthermia susceptible skeletal muscle in vitro. These studies provide evidence that azumolene is equipotent to dantrolene sodium in blocking pharmacologic-induced muscle contractures and that azumolene should be efficacious for treatment/prevention of malignant hyperthermia." @default.
• W2006048863 created "2016-06-24" @default.
• W2006048863 creator A5058580208 @default.
• W2006048863 creator A5065311066 @default.
• W2006048863 creator A5075722479 @default.
• W2006048863 creator A5090252220 @default.
• W2006048863 date "2007-11-28" @default.
• W2006048863 modified "2023-10-18" @default.
• W2006048863 title "Effects of Azumolene on Normal and Malignant Hyperthermia-Susceptible Skeletal Muscle" @default.
• W2006048863 cites W1803792965 @default.
• W2006048863 cites W1980391602 @default.
• W2006048863 cites W1989842375 @default.
• W2006048863 cites W2000639645 @default.
• W2006048863 cites W2030920510 @default.
• W2006048863 cites W2035808268 @default.
• W2006048863 cites W2047120941 @default.
• W2006048863 cites W2054597357 @default.
• W2006048863 cites W2056335161 @default.
• W2006048863 cites W2061635395 @default.
• W2006048863 cites W2069724642 @default.
• W2006048863 cites W2073697975 @default.
• W2006048863 cites W2078465267 @default.
• W2006048863 cites W2083049504 @default.
• W2006048863 cites W2087955851 @default.
• W2006048863 cites W2098288951 @default.
• W2006048863 cites W2114632792 @default.
• W2006048863 cites W2135160983 @default.
• W2006048863 cites W2136779301 @default.
• W2006048863 cites W2148269081 @default.
• W2006048863 cites W4251100015 @default.
• W2006048863 doi "https://doi.org/10.1111/j.1742-7843.2007.00156.x" @default.
• W2006048863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18047479" @default.
• W2006048863 hasPublicationYear "2007" @default.
• W2006048863 type Work @default.
• W2006048863 sameAs 2006048863 @default.
• W2006048863 citedByCount "21" @default.
• W2006048863 countsByYear W20060488632012 @default.
• W2006048863 countsByYear W20060488632013 @default.
• W2006048863 countsByYear W20060488632014 @default.
• W2006048863 countsByYear W20060488632016 @default.
• W2006048863 countsByYear W20060488632017 @default.
• W2006048863 countsByYear W20060488632018 @default.
• W2006048863 countsByYear W20060488632021 @default.
• W2006048863 countsByYear W20060488632023 @default.
• W2006048863 crossrefType "journal-article" @default.
• W2006048863 hasAuthorship W2006048863A5058580208 @default.
• W2006048863 hasAuthorship W2006048863A5065311066 @default.
• W2006048863 hasAuthorship W2006048863A5075722479 @default.
• W2006048863 hasAuthorship W2006048863A5090252220 @default.
• W2006048863 hasBestOaLocation W20060488631 @default.
• W2006048863 hasConcept C105702510 @default.
• W2006048863 hasConcept C126322002 @default.
• W2006048863 hasConcept C127607297 @default.
• W2006048863 hasConcept C134018914 @default.
• W2006048863 hasConcept C141071460 @default.
• W2006048863 hasConcept C185592680 @default.
• W2006048863 hasConcept C2776104385 @default.
• W2006048863 hasConcept C2776937108 @default.
• W2006048863 hasConcept C2778500429 @default.
• W2006048863 hasConcept C2778575482 @default.
• W2006048863 hasConcept C2779949491 @default.
• W2006048863 hasConcept C2779959927 @default.
• W2006048863 hasConcept C2781460320 @default.
• W2006048863 hasConcept C2910132651 @default.
• W2006048863 hasConcept C42219234 @default.
• W2006048863 hasConcept C519063684 @default.
• W2006048863 hasConcept C71924100 @default.
• W2006048863 hasConcept C98274493 @default.
• W2006048863 hasConceptScore W2006048863C105702510 @default.
• W2006048863 hasConceptScore W2006048863C126322002 @default.
• W2006048863 hasConceptScore W2006048863C127607297 @default.
• W2006048863 hasConceptScore W2006048863C134018914 @default.
• W2006048863 hasConceptScore W2006048863C141071460 @default.
• W2006048863 hasConceptScore W2006048863C185592680 @default.
• W2006048863 hasConceptScore W2006048863C2776104385 @default.
• W2006048863 hasConceptScore W2006048863C2776937108 @default.
• W2006048863 hasConceptScore W2006048863C2778500429 @default.
• W2006048863 hasConceptScore W2006048863C2778575482 @default.
• W2006048863 hasConceptScore W2006048863C2779949491 @default.
• W2006048863 hasConceptScore W2006048863C2779959927 @default.
• W2006048863 hasConceptScore W2006048863C2781460320 @default.
• W2006048863 hasConceptScore W2006048863C2910132651 @default.
• W2006048863 hasConceptScore W2006048863C42219234 @default.
• W2006048863 hasConceptScore W2006048863C519063684 @default.
• W2006048863 hasConceptScore W2006048863C71924100 @default.
• W2006048863 hasConceptScore W2006048863C98274493 @default.
• W2006048863 hasIssue "3" @default.
• W2006048863 hasLocation W20060488631 @default.
• W2006048863 hasLocation W20060488632 @default.
• W2006048863 hasOpenAccess W2006048863 @default.
• W2006048863 hasPrimaryLocation W20060488631 @default.
• W2006048863 hasRelatedWork W2002589200 @default.
• W2006048863 hasRelatedWork W2014260680 @default.
• W2006048863 hasRelatedWork W2038499644 @default.
• W2006048863 hasRelatedWork W2047120941 @default.
• W2006048863 hasRelatedWork W2053313689 @default.
• W2006048863 hasRelatedWork W2063136382 @default.
• W2006048863 hasRelatedWork W2064387568 @default.

• next